FDA Device recall Z-1423-2013
BBL DrySlide Oxidase Kit, catalog number 231746 Product Usage: Presumptive diagnostic aid for gram-negative bacteria
- FDA Device
- Class II
- terminated
- Published 2013-06-05
On 2013-06-05 the FDA classified a Class II recall of BBL DrySlide Oxidase Kit, catalog number 231746 Product Usage: Presumptive diagnostic aid for gram-negative bacteria by Becton Dickinson And, citing in-vitro diagnostic agents were placed into incorrect packaging for distribution to microbiological laboratories.
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-1423-2013 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2013-04-12 |
| Published | 2013-06-05 |
| Last updated | 2026-09-13 11:53 UTC |
| Company | Becton Dickinson And |
| Distribution | US |
Product
BBL DrySlide Oxidase Kit, catalog number 231746 Product Usage: Presumptive diagnostic aid for gram-negative bacteria.
Reason
In-vitro diagnostic agents were placed into incorrect packaging for distribution to microbiological laboratories.
Identifiers
| code_info | Oxidase kit - lot 2222008 with expiration date 08/31/13 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:53 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1423-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.